Standard BioTools Inc. Stock price
Equities
LAB
US34385P1084
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.705 USD | +0.56% | +0.37% | +22.62% |
Feb. 28 | Transcript : Standard BioTools Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Standard BioTools Inc. Provides Revenue Guidance for the Full Year 2024 | CI |
Financials (USD)
Sales 2024 * | 200M | Sales 2025 * | 235M | Capitalization | 1.03B |
---|---|---|---|---|---|
Net income 2024 * | -161M | Net income 2025 * | -69M | EV / Sales 2024 * | 5.15 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.38 x |
P/E ratio 2024 * |
-4.8
x | P/E ratio 2025 * |
-11.2
x | Employees | 537 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.56% |
Latest transcript on Standard BioTools Inc.
1 day | +1.89% | ||
1 week | +2.67% | ||
Current month | +19.56% | ||
1 month | +14.96% | ||
3 months | +22.27% | ||
6 months | -5.94% | ||
Current year | +21.72% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 23-05-14 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | Jan. 04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 22-03-31 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 23-03-14 |
Kathy Hibbs
BRD | Director/Board Member | 60 | Jan. 04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.71 | +0.74% | 215 250 |
24-03-27 | 2.69 | +1.89% | 1,444,933 |
24-03-26 | 2.64 | -2.22% | 1,702,867 |
24-03-25 | 2.7 | +0.75% | 1,474,455 |
24-03-22 | 2.68 | -0.74% | 1,872,940 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.72% | 1.03B | |
+9.15% | 221B | |
+18.60% | 142B | |
+18.70% | 101B | |
+7.83% | 68.07B | |
+24.79% | 57.27B | |
-2.49% | 47.42B | |
+6.00% | 43.19B | |
+16.80% | 41.12B | |
+14.13% | 28.84B |